PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.31%
This Fund
S&P 500
1 Year Est. Return
+47.31%
AUM
$2.72B
AUM Growth
-$567M
(-17%)
Holding
1,318
Top Buys
| 1 | +$38.5M | |
| 2 | +$4.12M | |
| 3 | +$3.3M | |
| 4 |
ConocoPhillips
COP
|
+$1.32M |
| 5 |
Coeur Mining
CDE
|
+$1.13M |
Top Sells
| 1 | +$71.9M | |
| 2 | +$27M | |
| 3 | +$24.6M | |
| 4 |
Microsoft
MSFT
|
+$22.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$17.8M |
Sector Composition
| 1 | Technology | 43.05% |
| 2 | Healthcare | 11.94% |
| 3 | Communication Services | 9.58% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Energy | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
TG Therapeutics
TGTX
$6.25B
| $2.53M | 0.09% |
76,039
+1,225
|
|
||
152
Axon Enterprise
AXON
$38.8B
| $2.52M | 0.09% |
5,936
-1,053
|
|
||
153
Strategy Inc
MSTR
$46.3B
| $2.52M | 0.09% |
20,161
-923
|
|
||
154
Sherwin-Williams
SHW
$73.2B
| $2.5M | 0.09% |
7,798
+417
|
|
||
155
Pan American Silver
PAAS
$22.3B
| $2.49M | 0.09% |
45,643
+2,289
|
|
||
156
Arrowhead Research
ARWR
$10.3B
| $2.49M | 0.09% |
39,758
+3,216
|
|
||
157
Ciena
CIEN
$88.5B
| $2.45M | 0.09% |
6,302
-1,985
|
|
||
158
GE HealthCare
GEHC
$28.1B
| $2.44M | 0.09% |
34,345
-8,936
|
|
||
|
159
Coeur Mining
CDE
$18.8B
| $2.44M | 0.09% |
130,230
+51,822
|
|
||
160
ASE Group
ASX
$87.4B
| $2.44M | 0.09% |
112,409
-23
|
|
||
161
Protagonist Therapeutics
PTGX
$6.02B
| $2.41M | 0.09% |
22,867
-2,707
|
|
||
162
Paychex
PAYX
$35.3B
| $2.4M | 0.09% |
26,076
-5,191
|
|
||
163
GE Vernova
GEV
$260B
| $2.36M | 0.09% |
2,706
-58
|
|
||
164
Cytokinetics
CYTK
$9.61B
| $2.35M | 0.09% |
35,713
-3,929
|
|
||
165
Arm
ARM
$437B
| $2.33M | 0.09% |
15,405
-2,936
|
|
||
166
Neurocrine Biosciences
NBIX
$16.5B
| $2.33M | 0.09% |
17,687
+1,987
|
|
||
167
Scholar Rock
SRRK
$5.38B
| $2.32M | 0.09% |
47,093
-1,059
|
|
||
168
Boeing
BA
$169B
| $2.31M | 0.08% |
11,621
+105
|
|
||
169
Halliburton
HAL
$34B
| $2.31M | 0.08% |
59,262
+15,017
|
|
||
170
Exelixis
EXEL
$12.9B
| $2.3M | 0.08% |
53,582
-3,468
|
|
||
171
TJX Companies
TJX
$174B
| $2.29M | 0.08% |
14,328
-2,210
|
|
||
172
Apogee Therapeutics
APGE
$6.22B
| $2.28M | 0.08% |
27,121
+8,845
|
|
||
173
Praxis Precision Medicines
PRAX
$7.61B
| $2.28M | 0.08% |
7,081
-1,374
|
|
||
174
Krystal Biotech
KRYS
$8.83B
| $2.27M | 0.08% |
8,790
-1,097
|
|
||
175
PTC Therapeutics
PTCT
$5.67B
| $2.27M | 0.08% |
33,326
+1,473
|
|